Inventor · disambiguated record
Philippe Guerry
Also filed as: GUERRY PHILIPPE
19 granted patents·205 citations·filing 1990–2020
94Inventor score
Files withHOFFMANN LA ROCHE10IDORSIA PHARMACEUTICALS LTD5BASILEA PHARMACEUTICA AG3ACTELION PHARMACEUTICALS LTD1
Top patents by PatentIndex Score
19 records- 0192US5239084ASubstituted aminoalkyl biphenyl compoundsHOFFMANN LA ROCHE·Filed 1992·Granted Aug 24, 1993·40 cites·3 claims
- 0291US7265125B2Neuropeptide Y antagonistsHOFFMANN LA ROCHE·Filed 2005·Granted Sep 4, 2007·18 cites·45 claims
- 0389US5177067ASubstituted aminoalkyl biphenyl compounds and method of treating fungal infectionsHOFFMANN LA ROCHE·Filed 1991·Granted Jan 5, 1993·33 cites·11 claims
- 0487US6821980B1Substituted 5-benzyl-2,4-diaminopyrimidinesBASILEA PHARMACEUTICA AG·Filed 2000·Granted Nov 23, 2004·30 cites·28 claims
- 0577US7524823B2MacrolidesBASILEA PHARMACEUTICA AG·Filed 2006·Granted Apr 28, 2009·5 cites·15 claims
- 0673US10202368B2CXCR7 receptor modulatorsIDORSIA PHARMACEUTICALS LTD·Filed 2015·Granted Feb 12, 2019·2 cites·16 claims
- 0773US9428456B21-[m-carboxamido(hetero)aryl-methyl]-heterocyclyl-carboxamide derivativesACTELION PHARMACEUTICALS LTD·Filed 2013·Granted Aug 30, 2016·3 cites·23 claims
- 0873US5106878AUse of substituted aminoalkoxybenzene derivatives in the control or prevention of fungal infectionsHOFFMANN LA ROCHE·Filed 1990·Granted Apr 21, 1992·28 cites·5 claims
- 0970US5214046ASubstituted aminoalkoxybenzene anti-fungicidal compositions and useHOFFMANN LA ROCHE·Filed 1992·Granted May 25, 1993·12 cites·23 claims
- 1069US9920010B2CXCR7 receptor modulatorsIDORSIA PHARMACEUTICALS LTD·Filed 2014·Granted Mar 20, 2018·2 cites·36 claims
- 1168US6995143B2Macrolides with antibacterial activityBASILEA PHARMACEUTICA AG·Filed 2003·Granted Feb 7, 2006·3 cites·57 claims
- 1268US5137920AMethod of treating fungal infectionsHOFFMANN LA ROCHE·Filed 1990·Granted Aug 11, 1992·10 cites·8 claims
- 1355US11306078B2Piperidine CXCR7 receptor modulatorsIDORSIA PHARMACEUTICALS LTD·Filed 2020·Granted Apr 19, 2022·0 cites·29 claims
- 1453US11339148B2Crystalline forms of the CXCR7 receptor antagonist (3S,4S)-1-Cyclopropylmethyl-4-{[5-(2,4-difluoro-phenyl)-isoxazole-3-carbonyl]-amino}-piperidine-3-carboxylic acid (1-pyrimidin-2-yl-cyclopropyl)-amideIDORSIA PHARMACEUTICALS LTD·Filed 2019·Granted May 24, 2022·0 cites·32 claims
- 1550US5763450ASubstituted benzyl pyrimidinesHOFFMANN LA ROCHE·Filed 1995·Granted Jun 9, 1998·9 cites·36 claims
- 1649US6900226B2Neuropeptide Y antagonistsHOFFMANN LA ROCHE·Filed 2001·Granted May 31, 2005·0 cites·76 claims
- 1746US6114330ASubstituted 2,4-diaminopyrimidinesHOFFMANN LA ROCHE·Filed 1998·Granted Sep 5, 2000·3 cites·210 claims
- 1846US5866583ASubstituted 2,4-diaminopyrimidinesHOFFMANN LA ROCHE·Filed 1997·Granted Feb 2, 1999·7 cites·92 claims
- 1945US10752620B2Piperdine CXCR7 receptor modulatorsIDORSIA PHARMACEUTICALS LTD·Filed 2017·Granted Aug 25, 2020·0 cites·29 claims
Join the waitlist — get patent alerts
Get an alert when Philippe Guerry files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →